Literature DB >> 17102947

A novel therapeutic option in Cogan diseases? TNF-alpha blockers.

M Fricker1, A Baumann, F Wermelinger, P M Villiger, A Helbling.   

Abstract

Cogan's syndrome is characterized by noninfectious, interstitial keratitis combined with a vestibulo-auditory deficit. Despite therapy with corticosteroids in combination with immunosuppressive agents, relapses occurred in two subjects and the clinical course suggested a progression of the disease. Treatment with anti-TNF-alpha was started leading to a rapid and sustained clinical remission for over 2 respectively 3 years.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17102947     DOI： 10.1007/s00296-006-0252-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  14 in total

1.  Cogan's syndrome: a rare vasculitis in childhood.

Authors:  O Kasapçopur; M Ashraf; S Caliskan; C Aktuglu; O S Aslan; F Oz; C Kosan; L Sever; N Arisoy
Journal:  J Rheumatol       Date:  2000-07       Impact factor: 4.666

2.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

3.  Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms; a long-term follow-up.

Authors:  E W NORTON; D G COGAN
Journal:  AMA Arch Ophthalmol       Date:  1959-05

4.  Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome.

Authors:  N B Allen; C C Cox; M Cobo; J Kisslo; M R Jacobs; R M McCallum; B F Haynes
Journal:  Am J Med       Date:  1990-03       Impact factor: 4.965

5.  Efficacy of methotrexate in Cogan's syndrome.

Authors:  L Riente; E Taglione; S Berrettini
Journal:  J Rheumatol       Date:  1996-10       Impact factor: 4.666

6.  Cogan's syndrome: 18 cases and a review of the literature.

Authors:  R S Vollertsen; T J McDonald; B R Younge; P M Banks; A W Stanson; D M Ilstrup
Journal:  Mayo Clin Proc       Date:  1986-05       Impact factor: 7.616

7.  Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature.

Authors:  B F Haynes; M I Kaiser-Kupfer; P Mason; A S Fauci
Journal:  Medicine (Baltimore)       Date:  1980-11       Impact factor: 1.889

8.  Cogan's syndrome: clinical significance of antibodies against the inner ear and cornea.

Authors:  C Helmchen; V Arbusow; L Jäger; M Strupp; W Stöcker; P Schulz
Journal:  Acta Otolaryngol       Date:  1999       Impact factor: 1.494

9.  [Serum antibodies against corneal and internal ear tissues in Cogan's syndrome].

Authors:  W Arnold; J O Gebbers
Journal:  Laryngol Rhinol Otol (Stuttg)       Date:  1984-08

10.  Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome.

Authors:  Claudio Lunardi; Caterina Bason; Massimo Leandri; Riccardo Navone; Maurizio Lestani; Enrico Millo; Umberto Benatti; Michele Cilli; Ruggero Beri; Roberto Corrocher; Antonio Puccetti
Journal:  Lancet       Date:  2002-09-21       Impact factor: 79.321
View more
  16 in total

1.  The use of TNF-alpha blockers in Cogan's syndrome.

Authors:  Zahi Touma; Rita Nawwar; Usamah Hadi; Mukbil Hourani; Thurayya Arayssi
Journal:  Rheumatol Int       Date:  2007-06-13       Impact factor: 2.631

2.  The use of biological therapy in refractory rheumatic diseases other than rheumatoid arthritis: experience at a tertiary care center in Lebanon.

Authors:  Khaled M Musallam; Thurayya Arayssi; Ali T Taher; Nadim Kanj; Imad Uthman
Journal:  Rheumatol Int       Date:  2008-12-04       Impact factor: 2.631

Review 3.  Cogan's syndrome--clinical guidelines and novel therapeutic approaches.

Authors:  Oshrat E Tayer-Shifman; Ophir Ilan; Hodaya Tovi; Yuval Tal
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

4.  Infliximab has no apparent effect in the inner ear hearing function of patients with rheumatoid arthritis and ankylosing spondylitis.

Authors:  H Toktas; E Okur; U Dundar; A Dikici; O K Kahveci
Journal:  Clin Rheumatol       Date:  2014-04-27       Impact factor: 2.980

5.  Interstitial keratitis and sensorineural hearing loss as a manifestation of rheumatoid arthritis: clinical lessons from a rare complication.

Authors:  Lennard Y W Lee; Mohammed Majid Akhtar; Othman Kirresh; Terence Gibson
Journal:  BMJ Case Rep       Date:  2012-12-14

6.  Unique topics and issues in rheumatology and clinical immunology.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

7.  Otosclerosis: an organ-specific inflammatory disease with sensorineural hearing loss.

Authors:  István Sziklai; Tamás József Batta; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-02       Impact factor: 2.503

Review 8.  Cogan's syndrome: present and future directions.

Authors:  Grainne Murphy; Miriam O Sullivan; Fergus Shanahan; Sinead Harney; Michael Molloy
Journal:  Rheumatol Int       Date:  2009-05-27       Impact factor: 2.631

Review 9.  COGAN'S SYNDROME.

Authors:  Daniela Adriana Iliescu; Cristina Mihaela Timaru; Mehdi Batras; Algerino De Simone; Cornel Stefan
Journal:  Rom J Ophthalmol       Date:  2015 Jan-Mar

10.  [Cogan's disease. Report of two cases].

Authors:  A Sandner; K Neumann; S Kösling; C Rasinski
Journal:  HNO       Date:  2010-07       Impact factor: 1.284
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.